SCHEMBL5370576

SCHEMBL5370576

Cc1ccc(S(=O)(=O)N(c2ccc(C(C)(C)C)cc2)c2ccc3ocnc3c2)cc1C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
THRB P10828 1/20 0.35
NR1H4 Q96RI1 4/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PTPN5 P54829 1/20 0.34
TP53 P04637 1/20 0.34
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
HCRTR2 O43614 1/20 0.32
KDM4E B2RXH2 2/20 0.32
POLB P06746 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373830 0.92 RXRA (0.40) SMN1; SMN2ALDH1A1GAAMEN1KMT2A
SCHEMBL5921908 0.90 TP53 (0.39) SMN1; SMN2THRBALDH1A1MEN1KMT2A
SCHEMBL5391241 0.89 ALDH1A1 (0.35) SMN1; SMN2THRBALDH1A1GAAMEN1
SCHEMBL5376611 0.88 SMN1; SMN2 (0.34) SMN1; SMN2THRBALDH1A1GAAMEN1
SCHEMBL5371938 0.85 TRPM8 (0.39) HCRTR2POLB
SCHEMBL5377050 0.82 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1GAAMEN1KMT2A
SCHEMBL5367888 0.82 GAA (0.37) SMN1; SMN2ALDH1A1GAAMEN1KMT2A
SCHEMBL5373225 0.81 TP53 (0.36) SMN1; SMN2ALDH1A1GAAMEN1KMT2A
SCHEMBL5368411 0.81 RXRA (0.39) SMN1; SMN2ALDH1A1GAAMEN1KMT2A
SCHEMBL5921895 0.81 TP53 (0.38) SMN1; SMN2THRBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD SMN1; SMN2 3404/4885THRB 160/4885NR1H4 21/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD SMN1; SMN2 3296/4885THRB 148/4885NR1H4 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.